Orderly Meds Review

Orderly Meds — Provider Profile

Overview

Orderly Meds is an online GLP-1 telehealth platform operating at orderlymeds.com, notable for offering both compounded and brand-name options within the same platform. At $149/mo for compounded semaglutide, pricing is competitive among full-service providers. Two features distinguish Orderly Meds from most competitors: oral compounded semaglutide tablets (rare among low-cost GLP-1 providers) and the ability to prescribe brand-name Wegovy and Zepbound when clinically appropriate.

The platform serves all 50 states, with providers licensed in every state. Consultations are primarily async, though six states require a video visit by state law. Ongoing care is managed through a patient portal with unlimited provider messaging included at no extra charge.

Third-party reviews are mixed. Trustpilot shows a 3.7/5 overall rating across 470+ reviews, with documented complaints about shipping delays, slow support response, and — in a small subset of reports — expired medication upon arrival.

April 2026 context: Orderly Meds offers compounded semaglutide and tirzepatide. These are not FDA-approved medications — they are prepared at state-licensed 503A compounding pharmacies under individual patient prescriptions. The FDA has taken enforcement action against compounders in this space and continues to pressure the sector. The regulatory environment for compounded GLP-1s is active and carries real risk. Orderly Meds does offer a brand-name pathway for patients who decide compounded medications are not appropriate for them — this is a meaningful differentiator.

Medications Offered

• Compounded semaglutide injectable — Not FDA-approved
• Compounded semaglutide oral tablet — Not FDA-approved; one of few low-cost providers offering an oral option
• Compounded tirzepatide injectable — Not FDA-approved; capped at 7.5mg (lower than many competitors who go to 15mg)
• Brand-name Wegovy — Available where clinically appropriate
• Brand-name Zepbound — Available where clinically appropriate

Pricing

Monthly pricing includes: telehealth consultation, medication, syringes, shipping, and unlimited provider messaging. Partner perks are also included (specific perks not listed on site).

States Served

All 50 states. Providers are licensed across all states. The majority of patients complete an async consultation; live video is required by state law in: Louisiana, Mississippi, New Mexico, Rhode Island, Kansas, and West Virginia.

Insurance

Cash-pay only. No insurance accepted for compounded medications. Brand-name pathways (Wegovy, Zepbound) are prescribed but insurance billing is managed outside the platform — patients with coverage would need to fill at a retail pharmacy using a separate prescription.

Consultation Process

Model: Primarily async; video required in 6 states.

1. Complete an online health questionnaire covering medical history, BMI, medications, and weight loss history
2. A licensed provider reviews within 24–48 hours via patient portal
3. If approved, medication is dispensed and shipped from a partner compounding pharmacy
4. Ongoing care via unlimited provider messaging — no additional per-message fees

For patients in Louisiana, Mississippi, New Mexico, Rhode Island, Kansas, or West Virginia: a video consultation is required before prescribing. Scheduling for video visits adds time to the initial approval window.

Pros

• Competitive $149/mo semaglutide pricing
• All 50 states with licensed providers in each
• Oral compounded semaglutide available — a meaningful option for patients who prefer tablets over injections
• Brand-name Wegovy and Zepbound available for patients who decide compounded is not the right fit
• 3-month starter bundle available
• Unlimited provider messaging included
• No long-term commitment required

Cons

• Trustpilot 3.7/5 across 470+ reviews — meaningfully mixed
• Documented shipping delays reported by a subset of patients (2–3+ week waits)
• Reports of expired medication on arrival in a small number of reviews
• Slow customer support response times noted in 2025 reviews
• Compounded tirzepatide capped at 7.5mg — lower than many competitors offering 15mg maximum
• Cash-pay only for compounded medications
• Compounded medications not FDA-approved; subject to active regulatory enforcement pressure
• Async-only model except in 6 states where video is required

Best For

Patients who want flexibility in their GLP-1 protocol. Orderly Meds serves two specific patient types well: (1) patients who prefer an oral semaglutide tablet over injections — a rare option at this price point — and (2) patients who want a compounded-first provider with a clear brand-name fallback if the regulatory landscape shifts or if their clinical situation changes.

Not ideal for: Patients who need to titrate tirzepatide above 7.5mg (Orderly Meds caps there), patients in the six video-required states who cannot schedule a video visit, or patients with low tolerance for support delays.

Editorial Verdict

Orderly Meds' dual-pathway model is genuinely useful. Most compounded GLP-1 providers offer compounded medications only — if the regulatory situation changes, patients have to switch platforms entirely. Orderly Meds' ability to prescribe brand-name Wegovy and Zepbound within the same provider relationship reduces friction if a patient's situation changes. The oral semaglutide option also fills a real gap for patients who have needle aversion or who prefer the tablet format.

The review profile tempers enthusiasm. A 3.7/5 across 470+ reviews with specific, recurring complaints about shipping delays and medication condition carries weight. These are not review-bombing patterns — they describe logistics failures that affect clinical outcomes. A patient expecting their medication in 3 days and waiting 2–3 weeks faces a real gap in treatment.

Patients who need or anticipate needing higher tirzepatide doses — the standard protocol often goes to 10–15mg — should look elsewhere. Orderly Meds caps at 7.5mg.

Bottom line as of April 2026: Orderly Meds is the right pick for patients who specifically want oral semaglutide or who want a compounded provider with a brand-name fallback. Go in knowing the support and shipping experience is variable. If tirzepatide at higher doses is the plan, this is not the platform.

Related Content

• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• GLP-1 Compounding Pharmacies: What Patients Need to Know — Full regulatory context
• GLP-1 Cost & Insurance FAQ — What you'll actually pay